Medicaid cuts off gender transition care for low-income patients.

What it does

This bill amends Medicaid and CHIP to prohibit federal funding for gender transition procedures, defined broadly to include surgeries, implants, and hormone treatments performed to change an individual's body to not correspond to their sex. The bill carves out exceptions for treating disorders of sex development and precocious puberty, and for reconstructive procedures following prior transition care. The effect is to bar Medicaid and CHIP from paying for these procedures, shifting costs to individuals, private insurance, or state-only funding.

Why we flagged it

The bill's operative mechanism is a categorical exclusion of a class of medical procedures from Medicaid and CHIP reimbursement. It is not a deregulation or a tax measure; it is a restriction on what federal health insurance programs may fund.

What the text implies

• The definition of 'sex' in subsections (4) and (5) relies on reproductive capacity, which may create ambiguity or litigation over intersex conditions, infertility, or post-menopausal individuals.
• The exception for 'medically necessary procedures' to correct disorders of sex development is narrow and requires physician certification; disputes over what qualifies may shift to state Medicaid agencies and courts.

The full analysis lists 4 implications of this text.

Who it affects

Low-income individuals enrolled in Medicaid or CHIP lose access to federally funded gender transition procedures, shifting costs to individuals, private insurance, or state-only programs. The bill restricts a medical benefit previously available to a vulnerable population without establishing medical necessity as the limiting principle—the exclusion is categorical and sweeping.